1989.6000 11.20 (0.57%)
NSE Aug 10, 2026 15:11 PM
Volume: 197.1K
 

Motilal Oswal
Since its inception in 1981, Emcure Pharmaceuticals (Emcure) has evolved into an R&D-driven diversified pharma franchise with a meaningful global scale built over the past decade through calibrated organic and inorganic investments across markets, platforms and capabilities.
Emcure Pharmaceuticals Ltd. is trading above all available SMAs
More from Emcure Pharmaceuticals Ltd.
Recommended